AptarGroup (ATR)
Materials · packaging and dispensing solutions · NYSE
AptarGroup is a global leader in drug delivery and consumer product dispensing solutions, providing specialized pumps, valves, and packaging for pharmaceutical and consumer goods markets.
What AptarGroup does
AptarGroup is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active packaging solutions. Its products are used extensively in the pharmaceutical, beauty, personal care, home care, food, and beverage markets. The company provides specialized dispensing systems, such as pumps, closures, and aerosol valves, along with elastomeric components and connected health devices.
Themes: pharmaceutical packaging, drug delivery technology, consumer product dispensing, medical devices, sustainable packaging
Fundamentals
- Price$134.80 as of 2026-08-21 close
- Market cap$8.6B as of 2026-08-21
- 1-year return-4.2% 2025-08-21 close $140.64 → 2026-08-21 close $134.80
- P/E23.34 as of 2026-08-24
- Net margin+9.2% as of 2026-08-24
- Gross margin+36.1% as of 2026-08-24
- ROE+13.6% as of 2026-08-24
- Debt / equity0.52 as of 2026-08-24
- Revenue growth (YoY)+8.9% as of 2026-08-24
- Revenue CAGR (3y)+4.4% SEC XBRL
- Beta0.34 as of 2026-08-24
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.3%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How ATR compares in its sector
- price-to-earnings ratiomiddle range 94 covered Materials peers, as of 2026-08-24
- net profit margintop 25% 142 covered Materials peers, as of 2026-08-24
- operating marginmiddle range 142 covered Materials peers, as of 2026-08-24
- gross margintop 25% 141 covered Materials peers, as of 2026-08-24
- return on equitymiddle range 151 covered Materials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- indicated dividend yieldmiddle range 95 covered Materials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)middle range 124 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ATR is in the Materials Short-term Top 10.
Materials Short-term Top 10 — since 18 Aug 2026
Long-term score
50.7 #469 of 987 scored · #19 of 66 in Materials
Capital return 71st (consecutive years of dividend increases 5 years) and long-term trend 52nd (a strong uptrend, with buyers in control); weakest is profitability (44th, operating margin 12.8%, return on equity 13.6%).
Short-term score
64.5 #66 of 1,704 scored · #1 of 83 in Materials
Setup 94th: no fresh 20-day breakout up or down; trend 60th: a strong uptrend, with buyers in control; weakest is momentum 51st: MACD momentum is negative.
In this list since 18 Aug 2026 — currently 1st in the list (3 days)
- Entered 18 Aug 2026: first selection for this list at rank 6, score 61.9.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, ATR's dividend was covered by reported results (earnings payout 31%, free-cash-flow payout 40%). This describes past coverage, not a forecast.
- Earnings payout31% dividends / net income
- Free-cash-flow payout40% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How AptarGroup looks technically
AptarGroup (ATR) is trading 7.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 9 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 28, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 19 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move.
Trend
9
| Distance from the 200-day | it is trading 7.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +7.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $128.94 | $128.94 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $125.78 | $125.78 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 129.56. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 9 trading days ago — a "golden cross", a bullish long-term signal | 9 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 7.2% above | +7.2% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 28, with buyers in control | 27.6 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30) | 58.7 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($129.56 to $137.66) — its "stochastic" reading is 65 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 64.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 11 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $146.91 | $146.91 |
|---|---|---|
| From the 52-week high | it is 8.2% below its 52-week high (its highest price of the past year) | -8.2% |
| Above the 52-week low | it is 30.6% above its 52-week low (its lowest price of the past year) | +30.6% |
| Below the 52-week high | it is 8.2% below its highest point of the past year | 8.2% |
| Since a 20-day breakout | it made a new 20-day high about 19 trading days ago | 19 sessions |
| Since a 55-day breakout | it made a new 55-day high about 19 trading days ago | 19 sessions |
| All-time high | its highest closing price on record is $178.03 (set on 2024-11-11) | $178.03 |
| Given back of the 52-week move | over the past year its closes ranged ($111.94 to $145.72), and it has recovered well over two thirds of its fall from last year’s high — 68% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $132.82 to $133.90. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 67.7% |
| From the all-time high | it is 24.3% below its all-time high | -24.3% |
| Nearest price level | it is trading 0.7% above a support level at $133.85 — a price it turned at three times since 2025-09-03, most recently on 2026-04-14. Since 2024-08-21 it has 6 such levels below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.7% |
| All-time low | its lowest closing price on record is $23.43 (set on 2006-07-14) | $23.43 |
| Above the all-time low | it is 475.3% above its all-time low | +475.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move | 0th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.75 between its high and its low — about 2.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.75 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $130.78 and $137.88 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $130.78 – $134.33 – $137.88 |
| Typical daily range (% of price) | its price moves about 2.0% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.0% |
| Stretch from the 200-day average | it is trading 3.3 daily ranges above its 200-day average price (7.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.90× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.8% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +0.8% |
|---|---|---|
| Open gap | it gapped 2.8% above the previous close 28 sessions ago and has not traded back through the level it left behind at 124.89 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.8% |
| Gap filled | a 2.4% gap up opened on 2026-08-03 has been "filled" 9 sessions ago — price traded back through the level the gap left behind, and it took 5 sessions to close | 9 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 3 sessions in a row, a +2.33% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 3 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 2.2 percentage points (the stock gained 4.6% while the market gained 2.3%) | +2.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 13.6 percentage points (the stock gained 16.7% while the market gained 3.1%) | +13.6% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.1 percentage points (the stock lost 7.1% while the market gained 11.1%) | -18.1% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 24.6 percentage points (the stock lost 4.2% while the market gained 20.5%) | -24.6% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 7.0% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 2.2% of the share price. | +7.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $127.42 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +5.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-07-30 (its 8-K), so the typical buyer over that stretch is roughly break-even. That average is $134.22 — a volume-weighted average of daily closes over 17 sessions, not a true tick-by-tick VWAP. | +0.4% |
Price levels it has turned at before
ATR last closed at $134.80 on 2026-08-21. Since 2024-08-21 it has turned at 6 prices below its last close and 9 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $133.85 | Support | 0.7% below the last close | turned there three times · 2025-09-03 to 2026-04-14 |
| $136.69 | Resistance | 1.4% above the last close | turned there three times · 2025-08-04 to 2026-07-17 |
| $130.70 | Support | 3.0% below the last close | turned there four times · 2025-04-07 to 2026-08-14 |
| $139.95 | Resistance | 3.8% above the last close | turned there three times · 2025-02-12 to 2026-07-31 |
| $127.02 | Support | 5.8% below the last close | turned there 7 times · 2025-10-16 to 2026-07-21 |
| $142.84 | Resistance | 6.0% above the last close | turned there twice · 2025-03-21 to 2025-08-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $129.56.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $140.74 and $147.64 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $129.56.
This reading has stood for 1 trading day, since 2026-08-21.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · in a Bollinger Band volatility squeeze · in a strong, established uptrend (ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · breakout · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.50 mean, 1=Strong Buy…5=Strong Sell) — 7 analysts
- Mean price target$170.14 range $155.00 – $220.00; median $164.00
Analyst estimates, as of 2026-08-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ATR
- Consensus EPS estimate$1.48 next reporting period, as of 2026-08-17
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Fluctuations in raw material costs and availability","Exposure to foreign currency exchange rate volatility","Risks associated with global supply chain disruptions"]
What changed in the latest 10-Q
AI-assisted comparison of ATR's 10-Q filed 2026-05-01 against the prior one filed 2025-10-31.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-01) presents Q1 2026 financial statements compared to Q1 2025; older filing (2025-10-31) presents Q3 2025 and nine-month 2025 financial statements compared to Q3 2024 and nine-month 2024
- Newer filing reports Q1 2026 Net Sales of $982,868 thousand vs Q1 2025 of $887,305 thousand
- Newer filing shows Q1 2026 Net Income Attributable to AptarGroup of $72,674 thousand vs Q1 2025 of $78,798 thousand
- Newer filing reports March 31, 2026 total assets of $5,097,783 thousand vs December 31, 2025 of $5,252,719 thousand
- Newer filing shows March 31, 2026 stockholders' equity of $2,647,557 thousand vs December 31, 2025 of $2,685,981 thousand
- Newer filing includes dividend per common share of $0.48 for Q1 2026 vs $0.45 for Q1 2025
- Removed:
- Older filing's nine-month period comparative data is absent from newer filing
- Older filing's reference to 'Gain from remeasurement of equity method investment' ($26,518 thousand in Q3 2025) does not appear in newer filing's Q1 2026 period
- Older filing's MD&A page reference at Item 2 is page 33; newer filing shows page 29
- Reworded:
- Older filing reports 'Net Loss Attributable to Redeemable Noncontrolling Interests' of $142 thousand; newer filing reports 'Net Income Attributable to Redeemable Noncontrolling Interests' of $89 thousand
- Balance sheet comparative dates changed from 'September 30, 2025 and December 31, 2024' (older) to 'March 31, 2026 and December 31, 2025' (newer)
- Statement of changes in equity comparative periods changed from 'September 30, 2025 and 2024' (older) to 'March 31, 2026 and 2025' (newer)
- Notes:
- The two filings cover different fiscal periods (Q1 vs Q3) and different comparison years, making direct financial metric comparisons reflect period-specific performance rather than methodological changes
- Text truncation in the cash flows statement in both versions prevents full assessment of that section
Risk Factors
- Added:
- Added comprehensive geopolitical risk factor discussing trade disputes, acts of war, terrorism, and their potential material adverse effects on operations (filed 2026-05-01)
- Added specific reference to Ukraine invasion by Russia, indirect impacts including higher energy costs and supply chain disruptions (filed 2026-05-01)
- Added disclosure of sanctions regimes relating to Russia and potential licensing impacts (filed 2026-05-01)
- Added discussion of Middle East conflicts and Iran-related developments causing potential supply chain delays and increased shipping costs (filed 2026-05-01)
- Added language about deterioration in U.S. relationships with other countries potentially resulting in trade sanctions, tariffs, and retaliatory actions (filed 2026-05-01)
- Added two new employment/letter agreements dated March 16, 2026 with Gael Touya and Stephan Tanda as exhibits (filed 2026-05-01)
- Added reference to February 3, 2026 share purchase authorization of up to $600.0 million replacing previous authorizations (filed 2026-05-01)
- Added share repurchase table for quarter ended March 31, 2026 showing 707,152 shares repurchased for $100.0 million (filed 2026-05-01)
- Added disclosure of no director or officer Rule 10b5-1 trading arrangements adopted, modified or terminated during Q1 2026 (filed 2026-05-01)
- Removed:
- Removed reference to Annual Report on Form 10-K for year ended December 31, 2024 (filed 2025-10-31)
- Removed entire section on risks from lawsuits and claims including product liability, Nemera patent infringement actions, and ARS Pharmaceuticals antitrust lawsuit (filed 2025-10-31)
- Removed entire section on challenges to intellectual property rights and litigation details (filed 2025-10-31)
- Removed specific details about Q3 2025 Plan activity (6,213 shares purchased at $140.64, 1,910 shares sold at $160.05) and Plan ownership of 123,497 shares at September 30, 2025 (filed 2025-10-31)
- Removed reference to October 10, 2024 share purchase authorization of up to $500 million (filed 2025-10-31)
- Reworded:
- Changed reference from 'Annual Report on Form 10-K for the year ended December 31, 2024' to 'Annual Report on Form 10-K for the year ended December 31, 2025' (filed 2026-05-01)
- Plan ownership changed from 123,497 shares at September 30, 2025 to 123,114 shares at March 31, 2026 (filed 2026-05-01)
- Updated quarter reference from 'three months ended September 30, 2025' to 'three months ended March 31, 2026' (filed 2026-05-01)
- Updated filing date references in exhibits from March 17, 2026 forms to current filing (filed 2026-05-01)
- Notes:
- The older filing text for Item 2 and beyond appears truncated at 'On October 10, 2024, a new share purchase authorization of up to $500 million of common stock was autho' making full comparison of all sections not possible
- Risk Factors section underwent substantial reorganization with geopolitical risks now prominently featured instead of litigation/IP risks in the newer filing
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 9 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 4 sells ($3M) — 3 selling insiders
- Last 90 days0 buys · 9 sells ($4M) — 4 selling insiders
- Last 180 days0 buys · 12 sells ($5M) — 6 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-04. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ATR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 1 matched disclosure for ATR from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding ATR as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 10,104,685
- Reported value $1,273,392,464
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
ATR had 1,835,928 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
ATR had 2.89% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.68 days to cover at the same settlement.
- Reported short interest (shares) 1,835,928
- Short interest (% of shares outstanding) 2.89%
- Prior settlement (shares) 1,839,198
- Reported change -0.18%
- Days to cover (reported) 3.68
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Berry Global (BERY)
- Amcor (AMCR)
- West Pharmaceutical Services (WST)
- Silgan Holdings (SLGN)
- Ball Corporation (BALL)
- Sonoco Products (SON)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ATR vs…
AptarGroup is found in…
Frequently asked questions
What does AptarGroup (ATR) do?
AptarGroup is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active packaging solutions. Its products are used extensively in the pharmaceutical, beauty, personal care, home care, food, and beverage markets. The company provides specialized dispensing systems, such as pumps, closures, and aerosol valves, along with elastomeric components and connected health devices.
What sector is AptarGroup (ATR) in?
AptarGroup (ATR) is classified in the Materials sector. Its industry is packaging and dispensing solutions. It trades on NYSE.
Does ATR pay a dividend?
Yes — AptarGroup (ATR) pays a dividend, with an indicated yield of about 1.28% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are AptarGroup's (ATR) competitors?
Notable peers of AptarGroup (ATR) include Berry Global, Amcor, West Pharmaceutical Services, Silgan Holdings and Ball Corporation. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in ATR?
Yes — we hold 1 matched STOCK Act disclosure for ATR from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is AptarGroup (ATR) overbought or oversold right now?
AptarGroup (ATR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 59, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ATR come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.